Philipp Lengsfeld Selected Research

Exanthema (Rash)

1/2020

Risk of Hypersensitivity Reactions to Iopromide After Intra-Arterial Versus Intravenous Administration: A Nested Case-Control Analysis of 133,331 Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philipp Lengsfeld Research Topics

Disease

5	Nephrogenic Fibrosing Dermopathy 08/2009 - 05/2008
4	Body Weight (Weight, Body) 04/2013 - 03/2009
3	Hypersensitivity (Allergy) 01/2022 - 03/2012
2	Asthma (Bronchial Asthma) 01/2020 - 03/2012
2	Hypoxia (Hypoxemia) 05/2012 - 02/2009
1	Exanthema (Rash) 01/2020
1	Cough 01/2020
1	Sneezing 01/2020
1	Erythema 01/2020
1	Urticaria (Hives) 01/2020
1	Pruritus (Itching) 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 09/2012
1	Renal Insufficiency (Renal Failure) 05/2010
1	Vascular System Injuries 12/2009
1	Thrombosis (Thrombus) 12/2009
1	Fibrosis (Cirrhosis) 08/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2008

Drug/Important Bio-Agent (IBA)

9	Contrast MediaIBA 01/2020 - 05/2008
5	GadoliniumIBA 12/2009 - 05/2008
4	iopromide (Ultravist)FDA Link 01/2022 - 12/2011
2	IodineIBA 04/2013 - 05/2012
2	iodixanol (Visipaque)FDA Link 05/2012 - 12/2011
1	Immunoglobulin E (IgE)IBA 01/2020
1	Plasminogen Activator Inhibitor 1IBA 09/2012
1	Lipocalin-2IBA 09/2012
1	Erythropoietin FDA Link 12/2009
1	IonsIBA 08/2009
1	ZincIBA 08/2009
1	Biomarkers (Surrogate Marker)IBA 02/2009
1	Phosphates (Orthophosphate)IBA 12/2008
1	LigandsIBA 05/2008

Therapy/Procedure

1	Intravenous Administration 01/2020
1	Intravenous Injections 12/2011
1	Diet Therapy (Therapy, Diet) 03/2009